FENC SG&A Expense Growth
Fennec Pharmaceuticals Inc · SG&A Expense Growth
FENC SG&A Expense Growth
Latest reported13.09%period ending
FENC FY SG&A Growth (YoY) (0.00% → 13.09%)
Latest values, visible window
High-resolution chart · PNG
FENC sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 13.0934% | |
| 26.8161% | |
| 59.4968% | |
| 67.5135% | |
| -5.4672% | |
| 70.9777% | |
| 40.2349% | |
| 7.6969% | |
| 109.0454% | |
| 46.8176% | |
| -35.1587% | |
| 88.9055% | |
| -13.657% | |
| -20.5247% | |
| -50.1027% | |
| 220.9226% | |
| -65.5114% | |
| 7.3826% | |
| 13.701% | |
| -9.3966% | |
| -8.9239% | |
| 96.1674% | |
| 96.278% | |
| 22.834% | |
| 0% | |
| 0% |